| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/NMO.12458 |
| P698 | PubMed publication ID | 25316608 |
| P2093 | author name string | H Han | |
| H Eutamene | |||
| L Bueno | |||
| H W Kim | |||
| M Gilet | |||
| P2860 | cites work | The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo | Q24671423 |
| Idiopathic constipation: too few stools and too little knowledge | Q33547871 | ||
| Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple n = 1 study | Q34230555 | ||
| Regulation of 5-HT release from enterochromaffin cells | Q34395364 | ||
| Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility | Q34650033 | ||
| Synthesis of specific bivalent probes that functionally interact with 5-HT(4) receptor dimers | Q34659586 | ||
| A serotonin transporter gene (SLC6A4) polymorphism is associated with reduced risk of irritable bowel syndrome in American and Asian population: a meta-analysis | Q34999672 | ||
| Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. | Q36336675 | ||
| Drugs acting on serotonin receptors for the treatment of functional GI disorders | Q36478089 | ||
| Novel therapeutic targets for enteric nervous system disorders | Q36926173 | ||
| The genetics of the serotonin transporter and irritable bowel syndrome. | Q37190229 | ||
| Selective desensitization of the 5-HT4 receptor-mediated response in pig atrium but not in stomach | Q37231016 | ||
| Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis | Q37496549 | ||
| Chronic psychological stress in rats induces intestinal sensitization to luminal antigens | Q38404556 | ||
| 5-HT(2B) receptors modulate visceral hypersensitivity in a stress-sensitive animal model of brain-gut axis dysfunction | Q39294409 | ||
| Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial | Q39319919 | ||
| Slow transit constipation: a functional disorder becomes an enteric neuropathy | Q42726168 | ||
| Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin | Q43361538 | ||
| Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum | Q44025590 | ||
| Cumulative incidence of chronic constipation: a population-based study 1988-2003. | Q44597003 | ||
| Regulation of ion transport by 5-hydroxytryptamine in rat colon | Q44965797 | ||
| 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine | Q45112735 | ||
| Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia | Q46541961 | ||
| Activation of peripheral 5-HT receptors attenuates colonic sensitivity to intraluminal distension | Q46863112 | ||
| Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome | Q46885942 | ||
| Isolation, functional characterization, and transcriptome of Mastomys ileal enterochromaffin cells | Q46925736 | ||
| Differential effects of 5-hydroxytryptamine4 receptor agonists at gastric versus cardiac receptors: an operational framework to explain and quantify organ-specific behavior | Q46963165 | ||
| Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells | Q48548051 | ||
| An in vitro investigation of the cardiovascular effects of the 5-HT(4) receptor selective agonists, velusetrag and TD-8954. | Q51755827 | ||
| Assessment of the pharmacological properties of 5-methoxyindole derivatives at 5-HT4 receptors | Q57098092 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 1761-1770 | |
| P577 | publication date | 2014-10-15 | |
| P1433 | published in | Neurogastroenterology and Motility | Q15767493 |
| P1476 | title | Influence of a new 5-HT4 receptor partial agonist, YKP10811, on visceral hypersensitivity in rats triggered by stress and inflammation | |
| P478 | volume | 26 |
| Q38376282 | Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges |
| Q36082843 | Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials |
| Q48350930 | Effect of prucalopride on intestinal gas tolerance in patients with functional bowel disorders and constipation |
| Q36828610 | Enteroendocrine cells: a review of their role in brain-gut communication |
| Q48168717 | Localization of the 5-hydroxytryptamine 4 receptor in equine enteric neurons and extrinsic sensory fibers. |
| Q38696256 | Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review |
| Q41392745 | Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article |
| Q48048742 | Prokinetic effects of a new 5-HT4 agonist, YKP10811, on gastric motility in dogs |
| Q88945541 | Prokinetics in the Management of Functional Gastrointestinal Disorders |
| Q39303889 | Sex-Related Differences in GI Disorders |
| Q47171305 | Stress-Induced Chronic Visceral Pain of Gastrointestinal Origin |
Search more.